ArcBest price target raised to $122 from $98 at UBS

UBS analyst Thomas Wadewitz raised the firm’s price target on ArcBest (ARCB) to $122 from $98 and keeps a Neutral rating on the shares. ArcBest reported stronger-than-expected volume growth in Q1, with tons per day rising 6.5% year over year and improving operating trends across its asset-based segment, the analyst tells investors in a research note. The outlook is supported by expectations for continued volume strength into Q2 and pricing tailwinds, with further earnings upside tied to a potential freight cycle recovery in 2027, though much of this optimism appears reflected in the current valuation, the firm says.